Fluzone® High-Dose Quadrivalent vaccine receives FDA approval for use in adults 65 years of age and older

The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone(R) High-Dose Quadrivalent (Influenza Vaccine) for use in adults 65 years of age and older. Fluzone(R) High-Dose (Influenza Vaccine) was approved by the FDA in 2009 as a trivalent influenza vaccine, including two influenza A strains and one influenza B strain. Fluzone ["]

The post Fluzone(R) High-Dose Quadrivalent vaccine receives FDA approval for use in adults 65 years of age and older appeared first on Outbreak News Today.